BioCentury
ARTICLE | Clinical News

Ariad preclinical data

May 3, 2010 7:00 AM UTC

In anaplastic lymphoma kinase ( ALK)-dependent non-small cell lung cancer (NSCLC) and anaplastic large cell lymphoma (ALCL) cell lines, AP26113 inhibited ALK with 10-fold greater potency compared to ...